These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11388647)

  • 1. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
    Matsui Y; Horiuchi K; Yamamoto K; Kanai K
    Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits.
    Tanaka H; Ohtsuka I; Kogushi M; Kimura T; Fujimori T; Saeki T; Hayashi K; Kobayashi H; Yamada T; Hiyoshi H
    Atherosclerosis; 1994 Jun; 107(2):187-201. PubMed ID: 7980693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
    Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
    Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys.
    Marzetta CA; Savoy YE; Freeman AM; Long CA; Pettini JL; Hagar RE; Inskeep PB; Davis K; Stucchi AF; Nicolosi RJ
    J Lipid Res; 1994 Oct; 35(10):1829-38. PubMed ID: 7852860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP 64477: a potent inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase with low systemic bioavailability.
    Bello AA; Bright C; Burton BJ; Bush RC; Casey JH; Dron DI; Facchini V; Joannou PP; Parrott DP; Riddell D; Roberts SA; Williams RJ
    Biochem Pharmacol; 1996 Feb; 51(4):413-21. PubMed ID: 8619885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.
    Murakami S; Ohta Y; Asami Y; Yamagishi I; Toda Y; Sato M; Tomisawa K
    Gen Pharmacol; 1996 Dec; 27(8):1383-6. PubMed ID: 9304411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.
    Rival Y; Junquéro D; Bruniquel F; N'Guyen X; Fauré P; Pomiès JP; Degryse AD; Delhon A
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):181-91. PubMed ID: 11791003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.
    Asami Y; Yamagishi I; Murakami S; Araki H; Tsuchida K; Higuchi S
    Life Sci; 1998; 62(12):1055-63. PubMed ID: 9519807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
    Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
    Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.
    Bocan TM; Mueller SB; Uhlendorf PD; Newton RS; Krause BR
    Arterioscler Thromb; 1991; 11(6):1830-43. PubMed ID: 1931885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
    Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
    Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
    Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
    Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.